Detalhe da pesquisa
1.
Incidence of liver cancer in young adults according to the global burden of disease database 2019.
Hepatology
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598364
2.
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.
Hepatology
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768142
3.
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clin Gastroenterol Hepatol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604296
4.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol
; 22(4): 789-797.e8, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048934
5.
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Liver Int
; 43(10): 2210-2219, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470077
6.
Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis.
Hepatol Res
; 53(12): 1213-1223, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574654
7.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res
; 53(4): 312-321, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524984
8.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(6): 489-496, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807720
9.
Gamma-glutamyl transferase predicts pemafibrate treatment response in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol
; 38(10): 1743-1749, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221601
10.
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Lab Invest
; 102(3): 281-289, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732847
11.
Serum levels of immunoglobulin M-free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Hepatol Res
; 52(12): 998-1008, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939571
12.
Real-world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old.
Hepatol Res
; 52(10): 859-871, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921253
13.
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia.
J Gastroenterol Hepatol
; 37(12): 2313-2320, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198983
14.
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Gastroenterology
; 158(6): 1611-1625.e12, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027911
15.
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-ß1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
Int J Mol Sci
; 22(24)2021 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34948151
16.
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Liver Int
; 40(7): 1686-1692, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342668
17.
Effect of pemafibrate on fatty acid levels and liver enzymes in non-alcoholic fatty liver disease patients with dyslipidemia: A single-arm, pilot study.
Hepatol Res
; 50(12): 1328-1336, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926754
18.
Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease.
Hepatol Res
; 50(4): 466-477, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31808236
19.
Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes.
Hepatol Res
; 50(7): 831-839, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32337818
20.
Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease.
Hepatol Res
; 49(6): 627-636, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716793